Crystallographic fragment screening in cancer and antiviral drug discovery: from electron density to translational outcomes

Esra Balıkçı, Jonathan M. Grimes

Open source

DOI
10.1080/17460441.2026.2754037
Published
2026-11-01
Container
Expert Opinion on Drug Discovery
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17460441.2026.2754037,
  title = {Crystallographic fragment screening in cancer and antiviral drug discovery: from electron density to translational outcomes},
  author = {Esra Balıkçı and Jonathan M. Grimes},
  year = {2026},
  journal = {Expert Opinion on Drug Discovery},
  doi = {10.1080/17460441.2026.2754037},
  url = {https://doi.org/10.1080/17460441.2026.2754037}
}

RIS

TY  - JOUR
TI  - Crystallographic fragment screening in cancer and antiviral drug discovery: from electron density to translational outcomes
AU  - Esra Balıkçı
AU  - Jonathan M. Grimes
PY  - 2026
JO  - Expert Opinion on Drug Discovery
DO  - 10.1080/17460441.2026.2754037
UR  - https://doi.org/10.1080/17460441.2026.2754037
ER  - 

APA

Balıkçı, E., & Grimes, J. M. (2026). Crystallographic fragment screening in cancer and antiviral drug discovery: from electron density to translational outcomes. Expert Opinion on Drug Discovery. https://doi.org/10.1080/17460441.2026.2754037

Source records